Systemic Immune-Inflammation Index Predicts Outcomes in Platinum-Resistant Relapsed Ovarian Cancer

Systemic Immune-Inflammation Index Predicts Outcomes in Platinum-Resistant Relapsed Ovarian Cancer

We explored the prognostic impact of simple indices that reflect the immunological milieu (neutrophils to lymphocyte ratio [NLR] and systemic immune-inflammation [SII]) in 49 platinum-resistant relapsed ovarian cancer patients. The median progression-free survival (PFS) and overall survival (OS) wer...

Full description

Saved in:

Bibliographic Details
Main Authors:	Luxitaa Goenka, Nakka Thejeswar, Biswajit Dubashi, Smita Kayal, Prasanth Ganesan
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2024-10-01
Series:	Indian Journal of Medical and Paediatric Oncology
Subjects:	platinum-resistant ovarian cancer treatment outcomes systemic immune-inflammation index neutrophil to lymphocyte ratio
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1749399
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Initial Neutropenia and Neutrophil Dynamics in Personalizing Chemotherapy for Platinum-Resistant Ovarian Cancer
by: Radu-Dumitru Dragomir, et al.
Published: (2025-03-01)

Ovarian cancer: new accents treatment of patients with platinum-sensitive relapses
by: A. G. Kedrova, et al.
Published: (2016-11-01)

Investigating the effect of optimal cytoreduction in the context of platinum sensitivity in high‐grade serous ovarian cancer
by: Nicholas Cardillo, et al.
Published: (2022-10-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2015-04-01)

Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study
by: Tamaki Tanaka, et al.
Published: (2025-06-01)

The prognostic impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on patients with small cell lung cancer receiving first-line platinum-based chemotherapy: a systematic review and meta-analysis
by: Yuansheng Zhao, et al.
Published: (2024-12-01)

Could the systemic immune-inflammation index be a new biomarker of inflammation in children with asthma?
by: Omer Okuyan, et al.
Published: (2025-03-01)

Deep learning based on ultrasound images to predict platinum resistance in patients with epithelial ovarian cancer
by: Chang Su, et al.
Published: (2025-05-01)

Preliminary study on the role and mechanism of ISG15 in exosomes in platinum resistance in ovarian cancer
by: TIAN Yanan, ZHENG Hui, YAN Tianqing, ZHANG Heng, LU Renquan, GUO Lin
Published: (2025-04-01)

The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
by: K. E. Borisov
Published: (2014-07-01)

Ojeok-san enhances platinum sensitivity in ovarian cancer by regulating adipocyte paracrine IGF1 secretion
by: Jiong Ma, et al.
Published: (2024-12-01)

Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity
by: Rachel M. Hurley, et al.
Published: (2025-06-01)

HELQ upregulates PARP1 to drive platinum resistance and predict therapeutic response in ovarian cancer
by: Shuran Tan, et al.
Published: (2025-07-01)

CT-based radiomics model to predict platinum sensitivity in epithelial ovarian carcinoma: a multicentre study
by: Mengge He, et al.
Published: (2025-07-01)

The clinical value of the neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio for predicting the severity of patients with autoimmune encephalitis
by: Xin Zhao, et al.
Published: (2025-02-01)

Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
by: Wang Caixia, et al.
Published: (2025-01-01)

CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation
by: Alessandra Dall'Acqua, et al.
Published: (2017-08-01)

Outcomes of Allogeneic Stem Cell Transplant in Chronic Myeloid Leukemia-Blast Phase: A Single-Center Experience from South India
by: Thejeswar Nakka, et al.
Published: (2025-06-01)

Pembrolizumab combined with lenvatinib and metronomic cyclophosphamide in platinum-resistant ovarian cancer: a case report of durable clinical response
by: Guanlin Dai, et al.
Published: (2025-08-01)

Utility of neutrophil to lymphocyte ratio in the prediction of inflammation and COPD mortality
by: Sanja Dimic-Janjic, et al.
Published: (2025-05-01)

Recurrent ovarian cancer: prolongation of the platinum-free interval with the use of a weekly treatment regimen of hycamtin (topotecan)
by: E. G. Novikova, et al.
Published: (2014-07-01)

The efficacy and peripheral blood predictors in recurrent platinum-resistant ovarian cancer patients treated with immune checkpoint inhibitors
by: Baoyue Pan, et al.
Published: (2025-08-01)

Long-term effect of pegylated liposomal doxorubicin in recurrent platinum-resistant ovarian cancer: а clinical case
by: I. A. Pokataev, et al.
Published: (2015-11-01)

Depression Symptoms and Inflammation in Chronic Functional Constipation Patients
by: Hamzah Shatri, et al.
Published: (2023-03-01)

Influence of initial platinum-based chemotherapy on levels of He-4 protein and VEGF-A in primary tumors and metastases from ovarian cancer
by: E. M. Frantsiyants, et al.
Published: (2022-01-01)

Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: a retrospective observational study
by: Alexandra R. Steck, et al.
Published: (2025-08-01)

The expression of immunohistochemical biomarkers PAX8 and CD117 in platinum resistant ovarian cancer at Saiful Anwar General Hospital, Malang, Indonesia
by: Robby Rinaldi Widodo, et al.
Published: (2025-04-01)

Bevacizumab in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Risk-Stratified Analysis
by: İrem Öner, et al.
Published: (2025-06-01)

The Effect of Neutrophil-to-Lymphocyte Ratio on Prognosis in Malignant Ovarian Germ Cell Tumors
by: Yagmur Arslan, et al.
Published: (2025-04-01)

Functional validation of somatic variability in TP53 and KRAS for prediction of platinum sensitivity and prognosis in epithelial ovarian carcinoma patients
by: Al Obeed Allah Mohammad, et al.
Published: (2025-12-01)

Day 3 neutrophil-to-lymphocyte ratio and its derived indices predict 90-day poor outcomes following mechanical thrombectomy in acute ischemic stroke patients
by: Weiwei Gao, et al.
Published: (2024-12-01)

The association between systemic immune inflammation index and disease activity in patients with rheumatoid arthritis
by: Anahita Amirpour, et al.
Published: (2024-06-01)

Immunohistochemical parameters of serous ovarian carcinomas and possible mechanism of development of resistance to platinum-based drugs
by: G. V. Zhukova, et al.
Published: (2024-09-01)

Tumor Small Extracellular Vesicle‐Transmitted LncRNA CATED Promotes Platinum‐Resistance in High‐Grade Serous Ovarian Cancer
by: Yi Liu, et al.
Published: (2025-08-01)

Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?
by: Bhatt Aditi, et al.
Published: (2024-07-01)

Association between nutritional inflammation index and diabetic foot ulcers: a population-based study
by: Zhou Lin, et al.
Published: (2025-01-01)

Neutrophil–Lymphocyte Ratio and KELIM Score as Prognostic Markers in High-Grade Serous Advanced Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy
by: Vasilis Theodoulidis, et al.
Published: (2025-04-01)

Ratios of neutrophils to lymphocytes and platelets to lymphocytes in ankylosing spondylitis with disease activity relationship
by: Shahla Taha Ahmad, et al.
Published: (2024-12-01)

The Quantitative Indices of ERCC1 Expression in Serous Ovarian Cancer Tissue and the Efficacy of First-Line Platinum-Based Chemotherapy
by: T. A. Bogush, et al.
Published: (2020-05-01)

The association between hematological markers of inflammation and chronic cannabis use: a systematic review and meta-analysis of observational studies
by: Reza Moshfeghinia, et al.
Published: (2024-10-01)